Related Experiment Video
Updated: Oct 9, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Stage II (N1) lung cancer
1Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California, USA.
Abstract:
As therapies evolve and mature, the authors predict that the next 20 years will see significant advances in the understanding of non-small-cell lung cancer (NSCLC), in molecular stratification of NSCLC, and significant improvement in survival and cure rates. This survival will be achieved through early detection and combined treatments using effective surgical interventions, improved radiotherapeutics, and especially significantly enhanced, rationally designed systemic therapies.
Insights
Future non-small-cell lung cancer (NSCLC) treatments will improve survival through early detection and combined therapies. Expect advances in molecular understanding and targeted systemic treatments over the next 20 years.
Area of Science:
- Oncology
- Translational Medicine
Background:
- Non-small-cell lung cancer (NSCLC) remains a leading cause of cancer mortality worldwide.
- Current treatment paradigms are evolving, necessitating a forward-looking perspective on therapeutic advancements.
Purpose of the Study:
- To forecast significant progress in NSCLC understanding and treatment over the next two decades.
- To highlight the anticipated impact of molecular stratification and novel therapeutic strategies on patient outcomes.
Main Methods:
- Predictive analysis based on current trends in oncology research and clinical practice.
- Review of emerging therapeutic modalities, including systemic therapies, surgery, and radiotherapeutics.
Main Results:
- Anticipation of major breakthroughs in the molecular understanding and stratification of NSCLC.
- Prediction of substantial improvements in survival and cure rates for NSCLC patients.
Conclusions:
- Early detection coupled with integrated treatment approaches will be key to enhancing NSCLC survival.
- Rationally designed systemic therapies, alongside surgical and radiotherapeutic advancements, will drive future treatment successes in NSCLC.
